(Q51823817)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415893%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Autologous stem cell transplantation in elderly (>60 years) patients with non-Hodgkin's lymphoma: a nation-wide analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415893%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415893%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Sirpa Leppä

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415893%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Jantunen E

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415893%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Itälä M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415893%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Juvonen E

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415893%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Keskinen L

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415893%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Vasala K

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415893%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Remes K

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415893%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Elonen E

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415893%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Nousiainen T

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415893%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

1 February 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415893%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415893%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415893%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415893%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

367-372

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415893%20AND%20SRC:MED&resulttype=core&format=json

Non-Hodgkin's lymphomas in elderly patients

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

Analysis of feasibility of myeloablative therapy and autologous peripheral stem cell (PBSC) transplantation in the elderly: an interim report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

Autologous blood and marrow transplantation in patients 60 years and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

Very low toxicity and good quality of life in 48 elderly patients autotransplanted for hematological malignancies: a single center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

Feasibility of peripheral blood progenitor cell mobilization and harvest to support chemotherapy intensification in elderly patients with poor prognosis: non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

High-dose myeloablative therapy and autologous peripheral blood progenitor cell transplantation for elderly patients (greater than 65 years of age) with relapsed large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the Eur

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

Palifermin for oral mucositis after intensive therapy for hematologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

7 January 2021

The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

7 January 2021

Peripheral stem cell mobilization and engraftment in patients over age 60

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

7 January 2021

Peripheral blood stem cell transplantation for relapsed or refractory aggressive lymphoma in patients over 60 years of age

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

7 January 2021

Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (>/=60 years) with non-Hodgkin's lymphoma: comparison with patients <60 years treated within the same protocol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

7 January 2021

High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

7 January 2021

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

7 January 2021

Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705266

7 January 2021